Riskpilot← Back to searchSign inGet full accessBiograil ApS
APSActiveCVR 40666699Langebjerg 1Research and experimental development on natural sciences and engineering · NACE 7210Est. 201921 employees
Revenue 2025
DKK -13,2M
-374% vs 2024
EBITDA margin
274.5%
-104% vs 2024
Equity ratio
93.9%
Financial strength
Net profit 2025
DKK -22,4M
-31% vs 2024
| Revenue | DKK -13,2M | -374% |
| EBITDA | DKK -36,2M | -104% |
| Net profit | DKK -22,4M | -31% |
| Total assets | DKK 108,8M | +45% |
| Equity | DKK 102,2M | +444% |
| Employees | 21 | — |
Legal name
Biograil ApS
CVR number
40666699
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
17. juli 2019
Share capital
DKK 492.114
Employees
21 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er udvikle avancerede medicinske produkter samt al virksomhed, som efter ledelsens skøn har forbindelse hermed.
Address
Langebjerg 1
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | -5.820 | -5.373 | 26.318 | -16.708 | 4.817 | -13.192 |
| Staff expenses | -2.780 | -3.654 | -9.685 | -16.554 | -22.536 | -23.016 |
| EBITDA | -8.600 | -9.028 | 16.632 | -33.262 | -17.719 | -36.209 |
| Depreciation & amort. | -81 | -82 | -157 | -248 | -338 | -567 |
| EBIT | -8.681 | -9.109 | 16.475 | -33.509 | -18.057 | -36.775 |
| Net financials | -123 | -68 | -3.599 | -8.197 | -4.031 | 8.905 |
| Profit before tax | -8.804 | -9.177 | 12.877 | -41.706 | -22.089 | -27.870 |
| Tax | -2.237 | -1.245 | -0 | -6.907 | -5.004 | -5.504 |
| Net profit | -6.567 | -7.932 | 12.877 | -34.799 | -17.084 | -22.367 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | 17.060 | 33.056 | 95.347 | 76.182 | 75.080 | 108.837 |
| Equity | 16.065 | 31.939 | 44.816 | 10.018 | 18.779 | 102.218 |
| Long-term debt | 73 | 0 | 48.320 | 61.387 | 0 | 0 |
| Short-term debt | 922 | 1.117 | 2.211 | 4.777 | 56.300 | 6.619 |
| Total debt | 996 | 1.117 | 50.532 | 66.164 | 56.300 | 6.619 |
EBITDA margin
-3620882300.0%
This company
15.8%
Market median
-22916976682% vs market
20202025
Equity ratio
93.9%
This company
38.2%
Market median
+146% vs market
20202025
Return on equity
-21.9%
This company
18.4%
Market median
-219% vs market
20202025
Net profit margin
-2236660500.0%
This company
8.1%
Market median
-27613092693% vs market
20202025
Asset turnover
-0.12×
This company
1.12×
Market median
-111% vs market
20202025
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20202025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2019-07-17 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JM Founder | Founder | 2019 | — | — |
KL Management | Management | 2019 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2019 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 15.0% | 15.0% | 2025 | |
MTI Biograil Invest A/S | Company | 15.0% | 15.0% | 2025 |
| Individual | 10.0% | 10.0% | 2025 | |
| Individual | 5.0% | 5.0% | 2025 | |
HELLERUNG ApS | Company | 5.0% | 5.0% | 2024 |
Lindhardt Holdings ApS | Company | 5.0% | 5.0% | 2025 |
| Individual | 5.0% | 5.0% | 2020 | |
Skak Tosanian Holding ApS | Company | 5.0% | 5.0% | 2019 |
| Individual | 5.0% | 5.0% | 2021 | |
| Individual | 5.0% | 5.0% | 2024 | |
Megatrend Invest A/S | Company | 20.0% | 20.0% | 2020 |
| Individual | 5.0% | 5.0% | 2021 | |
| Individual | 5.0% | 5.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
HELLERUNG ApS
Biograil ApS Board members of Biograil ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| John Michael Barberich | Founder | 0 companies |
| Karsten Lindhardt | Management | 0 companies |
| Anke Cassing | Board of Directors | 0 companies |
| Robert Samuel | Board of Directors | 0 companies |
| John Michael Barberich | Chairman | 0 companies |
| Ulrik Schulze | Board of Directors | 0 companies |
| Steffen Wagner | Board of Directors | 0 companies |
| Lars Hellerung Christiansen | Board of Directors | 0 companies |